Interest of 18F-FDG Positron Emission Tomography in the Management of Fevers and Inflammatory Syndromes

Evaluation of the Interest of 18F-FDG Positron Emission Tomography in the Management of Unexplained Fevers and Inflammatory Syndromes in Elderly Subjects

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04001491

Enrollment

150

Registered

2019-06-28

Start date

2019-08-01

Completion date

2020-08-31

Last updated

2019-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammation

Keywords

Inflammation, Inflammatory syndromes, fever, Tomography, Positron emission at 18F-FDG, Elderly patients, Internal medicine, Pet-Scan

Brief summary

Patients aged 75 and over represent a heterogeneous population with fragile subjects who have a higher risk of poor tolerance to many tests and especially who have a risk of major functional loss in the event of hospitalization. It is therefore necessary to adapt our prescriptions and not to impose on these patients an examination that is unnecessary. Or on the contrary, not to do without, out of ignorance, a minimally invasive examination that could be useful to these patients. In this study, the investigators wish to evaluate the interest of the Pet-Scan in the therapeutic management of these elderly patients

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

75 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patient aged 75 years and over, * Patients cared for at the HUS, in hospital or in consultation, during the defined period (from 01/05/2013 to 31/12/2018) * Having had an 18FDG-PET/TDM * For fever or inflammatory syndrome check-ups, regardless of the duration of the evolution and the examinations already carried out * Patient who has not expressed opposition to the reuse of their data for the purposes of this research.

Exclusion criteria

* Patient who has expressed opposition to participating in the study * Known explanation for fever or inflammatory syndrome * Subjects under legal protection * Subject under the protection of justice * Subject under guardianship or curatorship Translated with www.DeepL.com/Translator

Design outcomes

Primary

Measure	Time frame	Description
Evaluate the interest of the Pet-Scan in the therapeutic management of subjects aged 75 years and over with unexplained fever or inflammatory syndrome.	1 month	That is, to assess whether or not the therapeutic course of action has been modified by this examination, resulting in either the discontinuation or initiation of medical, surgical or radiotherapy treatment

Countries

France

Contacts

Primary ContactEmmanuel ANDRES, MD, PhD

emmanuel.andres@chru-strasbourg.fr33 3 88 11 50 66

Backup ContactCarole GREUEZ, MD

carole.greuez@chru-strasbourg.fr33 3 88 11 50 66

Outcome results